Mesh-Like suture could cut hernia risk after cancer surgery
NCT ID NCT07683546
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This trial tests whether a special mesh-like suture (Duramesh) can prevent incisional hernias better than a standard slowly-absorbable suture (PDS loop) in women having abdominal surgery for gynecological cancers. About 300 participants will be randomly assigned to one of the two closure methods. The study tracks hernia occurrence, wound healing, and pain for up to one year after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Duramesh (mesh suture) and PDS II 1-0 double loop suture
- What this could lead to
- If Duramesh works better, it could reduce the number of women who develop a hernia after major abdominal surgery for gynecological cancer.
- What could go wrong
- This is a single-center trial, so results may not apply to all hospitals. The mesh suture might also increase the risk of infection or other wound problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 85 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Midline laparotomies for gynecological malignancies * Age 18 - 85 years old * ECOG Performance status: 0 - 2 Exclusion Criteria: * Pregnancy * Albumin \< 3.5 g/dL * Previous history of any type of hernia * Previous midline incision (via laparotomy)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Duramesh are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping resistant tumors may extend life of cancer drugs
- Dental stitch showdown: which material is easiest on patients?
- Core exercises after abdominal surgery may cut hernia risk, study says
- Tension test: new study measures belly pressure during hernia repair
- Stitch showdown: which thread closes surgical wounds best?
- Mesh may stop hernias after big belly surgeries